Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT2 | Q96PD7 | 9/20 | 0.37 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | TNF | P01375 | 1/20 | 0.32 |
| ▸ | MGAT2 | Q10469 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.31 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.31 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.31 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1102592 | 0.95 | PDK2 (0.35) | DGAT2PIK3CDPDK2DHODHTNF | |
| SCHEMBL1102465 | 0.94 | DGAT2 (0.36) | DGAT2PIK3CDPDK2DHODHAKR1C3 | |
| SCHEMBL1102456 | 0.90 | DGAT2 (0.36) | DGAT2PIK3CDPDK2DHODHTNF | |
| SCHEMBL1102688 | 0.90 | PIK3CD (0.38) | DGAT2PIK3CDPDK2DHODHTNF | |
| SCHEMBL1102594 | 0.88 | KDR (0.39) | DGAT2PDK2DHODHTNFAKR1C3 | |
| SCHEMBL1102529 | 0.86 | CYP17A1 (0.36) | DGAT2PDK2AKR1C3AKR1C2KDR | |
| SCHEMBL1102570 | 0.86 | KDR (0.36) | DGAT2PIK3CDPDK2DHODHAKR1C3 | |
| SCHEMBL16298678 | 0.86 | LMNA (0.37) | DGAT2PIK3CDPDK2DHODHTNF | |
| SCHEMBL1102673 | 0.85 | PDK2 (0.37) | DGAT2PIK3CDPDK2DHODHTNF | |
| SCHEMBL1102515 | 0.85 | PDK2 (0.36) | DGAT2PDK2DHODHKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153279-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2012-04-10 | — | — | US | disclosed |
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | ORMDL3, OCIAD2, OCIAD1 | DGAT2 778/4885PIK3CD 1649/4885PDK2 1930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.